Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Site search
Search
Menu
Subscribe
Home
Contact Us
Terms of Use
Privacy Policy
Home Delivery
Subscribe
Submission Forms
Place an Ad
Weather
News
Sports
Entertainment
Calendar
Obituaries
Classifieds
Place an ad
e-Edition
Best of 2023
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Cellectar Biosc
(NQ:
CLRB
)
1.380
+0.020 (+1.47%)
Streaming Delayed Price
Updated: 11:56 AM EST, Dec 6, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Cellectar Biosc
< Previous
1
2
3
Next >
Cellectar Biosciences Reports Financial Results for Q3 2024 and Provides a Corporate Update
November 18, 2024
From
Cellectar Biosciences, Inc.
Via
GlobeNewswire
Earnings Scheduled For November 18, 2024
November 18, 2024
Via
Benzinga
Cellectar Biosciences and NorthStar Medical Radioisotopes Announce Partnership for Supply of Actinium-225
November 14, 2024
From
Cellectar Biosciences, Inc.
Via
GlobeNewswire
Cellectar Biosciences and SpectronRx Partner to Manufacture Novel Phospholipid Radioconjugate for the Treatment of Cancer
November 12, 2024
Cellectar broadens global manufacturing network in preparation for potential commercialization of Iopofosine I 131 in 2025
From
Cellectar Biosciences, Inc.
Via
GlobeNewswire
Earnings Preview For Cellectar Biosciences
March 26, 2024
Via
Benzinga
Gold Moves Higher; Coca-Cola Increases FY24 Forecast
July 23, 2024
Via
Benzinga
Why Comcast Shares Are Trading Lower By 6%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
July 23, 2024
Via
Benzinga
Recap: Cellectar Biosciences Q1 Earnings
May 04, 2023
Via
Benzinga
Crude Oil Down 2%; GE Aerospace Earnings Top Views
July 23, 2024
Via
Benzinga
Exposures
Fossil Fuels
Cancer-Focused Cellectar Biosciences Stock Trades Lower Despite Meeting Goal In Blood Cancer Study
July 23, 2024
Cellectar Biosciences stock drops 19.2% following the release of CLOVER WaM study results. The pivotal study for iopofosine I 131 in relapsed/refractory Waldenstrom's macroglobulinemia showed an 80%...
Via
Benzinga
CLRB Stock Earnings: Cellectar Biosciences Misses EPS for Q1 2024
May 14, 2024
CLRB stock results show that Cellectar Biosciences missed analyst estimates for earnings per share the first quarter of 2024.
Via
InvestorPlace
Hedgeye Warns That Reddit (RDDT) Stock Will Fall 50%
March 27, 2024
Reddit stock is a hot topic among traders on Wednesday after one analyst warns that RDDT could give up 50% of its gains.
Via
InvestorPlace
Why Is Gamida Cell (GMDA) Stock Down 82% Today?
March 27, 2024
Gamida Cell stock is falling on Wednesday with heavy trading of GMDA shares after the company announced plans to go private.
Via
InvestorPlace
CLRB Stock Earnings: Cellectar Biosciences Beats EPS for Q4 2023
March 27, 2024
CLRB stock results show that Cellectar Biosciences beat analyst estimates for earnings per share the fourth quarter of 2023.
Via
InvestorPlace
Earnings Scheduled For March 27, 2024
March 27, 2024
Companies Reporting Before The Bell • Local Bounti (NYSE:LOCL) is projected to report quarterly loss at $2.41 per share on revenue of $8.70 million.
Via
Benzinga
Cellectar Biosciences Is An 'Attractive Acquisition Target' According To This Analyst - Here's Why
March 04, 2024
Cellectar Biosciences reports positive Phase 1 trial results for iopofosine I 131 in head and neck squamous cell carcinoma, achieving 64% complete remission and 73% overall response rate. Roth Capital...
Via
Benzinga
Why Is Cancer-Focused Cellectar Biosciences Stock Trading Higher Today?
January 08, 2024
Cellectar Biosciences Inc (NASDAQ: CLRB) announced data from its CLOVER WaM pivotal study, evaluating iopofosine I 131, a targeted radiotherapy candidate for the treatment of relapsed/refractory...
Via
Benzinga
Wells Fargo Is Warming Up to Enphase Energy (ENPH) Stock
January 08, 2024
Enphase Energy stock is rising higher on Monday as investors react to a new upgrade and increased price target for ENPH from Wells Fargo.
Via
InvestorPlace
Why Is Spirit AeroSystems (SPR) Stock Down 14% Today?
January 08, 2024
Spirit AeroSystems stock is falling hard on Monday as investors in SPR react to one of the company's flights experiencing a mid-air blowout.
Via
InvestorPlace
Why Is LumiraDx (LMDX) Stock Down 13% Today?
January 08, 2024
LumiraDx stock is falling hard on Monday as investors in LMDX prepare for the company's shares to be delisted on Tuesday!
Via
InvestorPlace
Why Is Cellectar Biosciences (CLRB) Stock Up 16% Today?
January 08, 2024
Cellectar Biosciences stock is up on Monday as investors celebrate positive study results with heavy trading of CLRB stock this morning.
Via
InvestorPlace
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
January 08, 2024
It's time to start the week with a breakdown of the biggest pre-market stock movers worth keeping an eye on for Monday morning!
Via
InvestorPlace
12 Health Care Stocks Moving In Friday's Intraday Session
September 22, 2023
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
September 06, 2023
Via
Benzinga
Crude Oil Rises 1%; Verb Technology Shares Spike Higher
September 05, 2023
U.S. stocks traded mostly lower toward the end of trading, with the Dow Jones falling 100 points on Tuesday. The Dow traded down 0.31% to 34,728.66 while the NASDAQ rose 0.11% to 14,047.61. The S&P...
Via
Benzinga
Topics
Stocks
Exposures
Fossil Fuels
US Equities
Nasdaq Turns Higher; US Factory Orders Fall 2.1% In July
September 05, 2023
U.S. stocks traded mixed midway through trading, with the Nasdaq Composite turning higher on Tuesday. The Dow traded down 0.15% to 34,785.92 while the NASDAQ rose 0.12% to 14,048.20. The S&P 500, also...
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Why America's Car-Mart Are Trading Lower By 12%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
September 05, 2023
Gainers Verb Technology Company, Inc. (NASDAQ: VERB) shares jumped 164% to $1.89 after the completed and launched a technology integration and strategic relationship with global social media platform...
Via
Benzinga
Cellectar Biosciences Inc. (NASDAQ: CLRB) Near Top of Volume Charts in Tuesday Trading
September 05, 2023
Via
Investor Brand Network
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
September 05, 2023
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
March 01, 2023
Via
Benzinga
< Previous
1
2
3
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.